About
Our Company
Leadership
Advisors
Careers
Contact
Focus
IBAL
Research
Anticancer
Antimicrobial
Prevention
Pipeline
API Developments
Anti-inflammatory
Oncology
Ion Gel ZCM-25
Infections
Wound Healing
Skin Cancers
Preclinical
Clinical
Media
News
Partners
Investors
Contact
Español
Search for:
June 7, 2020
Ion Gel ZCM-25® cGMP Manufactured - Antivirus Test on SARS-CoV-2
Preclinical
In 2020 LEI Labs in Mexico City determined and certified that a cGMP Manufactured Ion Gel ZCM-25 had a kill rate of 99.9999% in 10 minutes on the SARS-CoV-2 Virus.
Related Publications
Ion Gel ZCM-25® Anti-MRSA Disinfectant Activity By a Bacterial Challenge MRSA
August 5, 2020
Ion Gel ZCM-25® Antifungal Disinfectant Activity by Fungicide Challenge – Aspergillus Brasiliensis
August 3, 2020
Ion Gel ZCM-25® cGMP Manufactured - Antimicrobial Test on 3 Bacteria
April 2, 2020
Dermal Irritability Single High Dose Study of Ion Gel ZCM-25® on New Zealand Male Rabbits
August 13, 2019
ION-ZCM1 Oxygen Radical Absorbance Capacity Orac Activity Assay
November 16, 2018
ION-ZCM1 – Cell-Based In Vitro Toxicity Study
November 15, 2018
ION-ZC1 In Vitro Antimicrobial Study On Biofilm
September 16, 2018
ION-ZCM1 Redox Potential Assay
June 16, 2018
Preliminary Evaluation Of ION-ZC1 As A Potential Anticancer Agent In Vitro
April 15, 2018
close
angle-right
magnifier
cross
menu-circle